Start out I am a big GHDX holder. BRlI numbers came out, strong just like GHDX. Lab companies are showing strong growth, but their SP has not reflected it. Anyone know why, and any thoughts on more Lab companies being bought up. Thnaks in advance, own both was hoping for some more buyouts.
I have relatively small holdings in a number of biotechs, recognizing that they're inherently speculative and that you're hoping for one major winner to carry you. I would only note that GHDX seems to have some real sponsorship and does not sell off on market weakness as many of these do. In fact, on days when the market is weak, it often moves up, which suggests that it may be under accumulation. Thinking of adding some more.